Revanesse Lips+ with Lidocaine

Revanesse Lips+ emerges as a revolutionary FDA-approved hyaluronic acid (HA) dermal filler, meticulously engineered to restore lost volume and impart a fuller-looking pout to patients seeking lip enhancement. Renowned for its immediate results and capacity for new collagen growth stimulation, Revanesse Lips+ sets a new standard in lip augmentation, offering unparalleled benefits for individuals yearning for youthful, luscious lips. 

This advanced dermal filler boasts a myriad of advantages, including less swelling post-treatment, facilitating easy visualization for practitioners to ensure precise volume correction and balanced results. Its FDA approval in 2017 underscores its safety profile, with no serious adverse reactions reported during rigorous clinical trials. With over one million syringes administered globally since its release, Revanesse Lips+ epitomizes reliability and efficacy, manufactured in small batches under stringent quality standards to guarantee optimal results. 

Revanesse Lips+ is formulated with lidocaine, obviating the need for numbing cream and streamlining the injection process for enhanced patient comfort. Administered via an ultrafine needle into the mid- or deep-dermis of the skin, this filler offers swift appointments with minimal swelling, allowing patients to resume their routine activities promptly. Post-treatment care is minimal, with minor swelling and bruising expected to subside within a few days. Results are immediate, with the filler settling completely over the subsequent weeks, augmented by the synthesis of new collagen for sustained enhancement.

At its core, Revanesse Lips+ harnesses the power of hyaluronic acid, a naturally occurring substance in the body renowned for its ability to attract moisture and maintain skin hydration and suppleness. Crosslinked with 1,4-butanediol diglycidyl ether (BDDE), Revanesse Lips+ embodies a gel formulation injected directly into the lips to temporarily plump and enhance them for individuals aged 22 and above. The inclusion of lidocaine further enhances injection comfort by reducing pain sensitivity, ensuring a seamless and pain-free experience. 

Notably, clinical trials have underscored Revanesse Lips+'s superiority, with 100% of patients achieving improved outcomes at the 6-month post-treatment mark, as rated by physicians. Patients themselves reported a high satisfaction rate, with 96.3% expressing improvement at the same milestone. Moreover, Revanesse Lips+ boasts 50% less swelling post-treatment compared to competing fillers, and up to 70% of patients still experienced fuller lips one year after treatment. 

Revanesse Lips sets itself apart from other lip fillers through its unique manufacturing process, which ensures hyaluronic particles remain closely packed, spherical in shape, and consistent in size. This meticulous approach, coupled with the incorporation of lidocaine for enhanced comfort, sets the stage for unparalleled, natural-looking results that stand the test of time.